Fundz
Free weekly newsletter

Get the free weekly funding digest

The new funding rounds, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New funding rounds, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Industry Trends

See who's moving and how much in your market

No credit card required Weekly funding digest

Nkarta, Inc. Launches $100 Million At-the-Market Offering

PUBLIC · NKTXMar 26, 20263 months ago

Amount Raised

$100 Million

Round Type

at-the-market offering

San FranciscoBiotechnology

Investors

Stifel, Nicolaus & Company, Incorporated

Description

On March 25, 2026, Nkarta, Inc. entered into a Sales Agreement with Stifel, Nicolaus & Company, Incorporated for an at-the-market offering program. This program will allow Nkarta to sell up to $100 million of its common stock at its discretion. The shares will be sold under the parameters set by Nkarta through Stifel as the sales agent.

Company Information

Company

Nkarta

Location

San Francisco, California, United States

About

Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, and engineered to enhance tumor targeting and improve persistence for sustained activity in the body.

Related People

Suggested for you
1 contact

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Nkarta's next move

Learn about Strategic plan

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.

Watching Nkarta? See every signal — funding, hires, M&A, contracts, sentiment.

Request a demoChoose your plan